380 INTERLOCKEN CRES # 780 SUITE 780 BROOMFIELD, CO 80021 Get Directions
380 INTERLOCKEN CRES # 780 SUITE 780 BROOMFIELD, CO 80021 Get Directions
Founded 2001
Incorporated CO
Annual Revenue $10,051,502.00
Employee Count 42
Industries Manufacturing - Druggists' Preparations (pharmaceuticals)
Contacts Charles Stacey Accera discovers and develops breakthroughs in treating central nervous system disorders, focusing on serious and difficult-to-diagnose neurodegenerative diseases for which there are no simple tests, no cures and a lack of new, innovative treatments to improve quality of life for patients and their families. The company is pioneering unique scientific approaches to treating CNS disorders, through products with novel mechanisms-of-action that target the underlying factors giving rise to symptoms.
Currently our product pipeline includes therapeutic treatments for Parkinson's disease, Alzheimer's disease and other age-related memory loss disorders. These products are in advanced clinical development where they have demonstrated significant efficacy and outstanding safety compared to approved drugs in the marketplace.
Through our proprietary scientific platform, Accera is developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. Based on our proprietary platform, our first product for Alzheimer's (Axona) targets metabolic defects in brain neurons.
As an industry innovator, Accera's new and novel therapeutic approaches positively impact patients with neurodegenerative disorders, who are in need of effective, well-tolerated treatments, and their families. We are committed to improving the care and quality of life of patients.
VERIFIED Status:
UNVERIFIED
Address:
LAST VERIFIED:
--
Phone:
Payment Method:
Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.